FDA Inspection
District Hospital Partners LPDistrict Hospital Partners LP – FDA Inspection, Sep 17, 2018
Record Details
This FDA Inspection record concerns District Hospital Partners LP, with an inspection on September 17, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 77572d63-62e3-451a-a023-958a5996b027
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1066516
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.151(e)Procedures to maintain records of emergency transfusions
Full citation text and observation details available on the Dashboard.
Other FDA inspections of District Hospital Partners LP
6| Date | Classification | Office | Project area |
|---|---|---|---|
| November 25, 2024 | VAI | Baltimore District Office | Blood and Blood Products |
| September 21, 2022 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 21, 2016 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 15, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 31, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for District Hospital Partners LP
- FDA Inspection 1255152 - 2024-11-25
- FDA Inspection 1181339 - 2022-09-21
- FDA Inspection 978098 - 2016-07-21
- FDA Inspection 875282 - 2014-04-15
- FDA Inspection 797591 - 2012-08-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.